Search research articles
Contact Us
Filters
Showing results (41-50 of 452) with videos related to
Page
of 46
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
September 26, 2009
Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology
J Gabrielsson, A R Green
British Journal of Pharmacology
|
September 1, 1971
Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization
G Curzon, A R Green
Neuropharmacology
|
December 1, 1978
Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens
D J Heal, A R Green
British Journal of Clinical Pharmacology
|
December 1, 1980
Metabolism of an oral tryptophan load III: effect of a pyridoxine supplement
A R Green, J K Aronson
European Journal of Pharmacology
|
July 14, 1995
The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones
M I Colado, A R Green
Nature
|
May 22, 1980
Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour
A R Green, J F Deakin
Neuropharmacology
|
April 1, 1980
Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock
C K Atterwill, A R Green
British Journal of Pharmacology
|
March 1, 1977
The effect of iron deficiency on brain monoamine metabolism and the behavioural responses to increased brain 5-hydroxytryptamine and dopamine synthesis [proceedings]
A R Green, M B Youdim
Neuropharmacology
|
December 1, 1994
Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats
K E Hewitt, A R Green
International Review of Neurobiology
|
January 1, 1997
Techniques for examining neuroprotective drugs in vivo
A R Green, A J Cross
Page
of 46
Search research articles
Search
Showing results (41-50 of 452) with videos related to
Sort By:
Page
of 46
The Journal of Pharmacology and Experimental Therapeutics
|
September 26, 2009
Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology
J Gabrielsson, A R Green
British Journal of Pharmacology
|
September 1, 1971
Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization
G Curzon, A R Green
Neuropharmacology
|
December 1, 1978
Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens
D J Heal, A R Green
British Journal of Clinical Pharmacology
|
December 1, 1980
Metabolism of an oral tryptophan load III: effect of a pyridoxine supplement
A R Green, J K Aronson
European Journal of Pharmacology
|
July 14, 1995
The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones
M I Colado, A R Green
Nature
|
May 22, 1980
Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour
A R Green, J F Deakin
Neuropharmacology
|
April 1, 1980
Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock
C K Atterwill, A R Green
British Journal of Pharmacology
|
March 1, 1977
The effect of iron deficiency on brain monoamine metabolism and the behavioural responses to increased brain 5-hydroxytryptamine and dopamine synthesis [proceedings]
A R Green, M B Youdim
Neuropharmacology
|
December 1, 1994
Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats
K E Hewitt, A R Green
International Review of Neurobiology
|
January 1, 1997
Techniques for examining neuroprotective drugs in vivo
A R Green, A J Cross
Page
of 46